J .A. Zuris. Best Practices for Achieving Optimal Ex Vivo Genome Editing in Your Research. Presented at the 23rd ASGCT Annual Meeting, May 12-15, 2020.

Dec

9

Editas Medicine Reports Updated Clinical Data from the RUBY Trial of Reni-cel in Patients with Severe Sickle Cell Disease at the American Society of Hematology (ASH) Annual Meeting

Nov

6

Editas Medicine to Participate in Upcoming Investor Conferences

Nov

4

Editas Medicine Announces Third Quarter 2024 Results and Business Updates